Cashu | Summary

DJI

+0.72%

SPX

+0.62%

IXIC

+0.61%

FTSE

+0.34%

N225

+1.65%

AXJO

-0.10%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.72%

SPX

+0.62%

IXIC

+0.61%

FTSE

+0.34%

N225

+1.65%

AXJO

-0.10%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

282.14M

Dividend Yield

0.00%

P/E Ratio

-3.31

EPS

-1.20

Revenue

1.45M

Avg. Volume

455.57K

About

What does CATX do?

Perspective Therapeutics, based in Seattle, is a biotechnology company focused on developing radiopharmaceuticals for cancer treatment using the alpha-emitting isotope 212Pb. Their programs for melanoma and neuroendocrine tumors are in Phase I/IIa trials.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

Washington, USA

Website

http://www.isoray.com